Richard J Gayeski, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 16a Manor Ave, Millersville, PA 17551 Phone: 717-872-5444 |
Jon H Schrock, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 16a Manor Ave, Millersville, PA 17551 Phone: 717-872-5444 |
Robert J Baird, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 16a Manor Ave, Millersville, PA 17551 Phone: 717-872-5444 |
Julie L Jones, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 16a Manor Ave, Millersville, PA 17551 Phone: 717-872-5444 |
Jon R Ichter, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 16a Manor Ave, Millersville, PA 17551 Phone: 717-872-5444 |
Dr. Jennifer Liddell Kaminstein, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 16 Manor Ave Ste A, Millersville, PA 17551 Phone: 717-872-5444 |
Catherine J Edmonds, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 16a Manor Ave, Millersville, PA 17551 Phone: 717-872-5444 |
Lindsay Alexandra Lafferty, M.D. Family Medicine - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 16 Manor Ave Ste A, Millersville, PA 17551 Phone: 717-872-5444 |
Peter J Altimare, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 16a Manor Ave, Millersville, PA 17551 Phone: 717-872-5444 |
Dr. David H Emmert, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 16a Manor Ave, Millersville, PA 17551 Phone: 717-872-5444 Fax: 717-872-1537 |
News Archive
Since the advent of effective antiretroviral therapy, human immunodeficiency virus infection has become more like a chronic illness.
Unique molecular mechanics allowing parasites to thrive in the guts of one billion people open the door to new treatments that are safe for the host.
Advanced Cell Technology, Inc. announced today that it is positioned to obtain significant patents relating to cellular reprogramming and the generation of induced pluripotent stem (iPS) cells. iPS cells are similar to embryonic stem (ES) cells, except they are generated from adult cells such as skin using certain reprogramming factors, without the controversial use of embryos. Although human iPS cells were first produced in 2007, ACT has been working on inducing pluripotency, with positive results, for more than a decade. The Company's efforts go back to the 1990s, providing (through existing patent filings and continuations) some of the earliest priority dates in the field.
Dementia and other tauopathies, most notably Alzheimer's disease, embody a class of neurodegenerative diseases associated with the aggregation of the Tau protein in the human brain. These diseases represent one of the leading causes of death and disability in the elderly population in the western world, with no current effective therapy.
› Verified 2 days ago